What is semaglutide?
Semaglutide copies GLP-1, the fullness hormone your gut releases after eating — slowing digestion, quieting appetite, and steadying blood sugar. It's one of the most-studied molecules in modern metabolic medicine.
These articles cover it from every angle: mechanism, dosing, side effects, results measured in trials, and how compounded semaglutide differs from brand-name versions. It's prescription-only through Promise: a licensed provider reviews every request, and not everyone qualifies. If you're starting from zero, begin with the mechanism article — the rest makes more sense once the hormone story is clear.
96 articles on this topic
-
Does Semaglutide Increase Heart Rate?
Yes, semaglutide can raise resting heart rate by a few beats per minute on average. A steady rise or a racing heartbeat at rest deserves a closer look, because an average cannot explain one person's symptoms.
-
Wegovy Prescribing Information, Explained
The current Wegovy label is revised June 2026. It covers weight, cardiovascular and MASH uses; the injection dose ladder including 7.2 mg; the boxed warning; common reactions; pregnancy; and device formats.
-
What Is an IND? A Plain-English FDA Guide
An IND is the filing that lets a sponsor begin testing an investigational drug in people. It opens a research path, not a sales or prescription path.
-
5 Percent Weight Loss Benefits: Study Numbers
Five percent can be a meaningful first milestone. Here's what studies measured in blood sugar, blood pressure, and sleep, and where the numbers stop being a useful prediction.
-
Does Semaglutide Cause Headaches? The Facts
Headache is a recognized side effect, but the timing alone doesn't explain it. The trial rates, possible triggers, and symptoms that need prompt care.
-
SELECT Trial Semaglutide Results: What 20% Means
SELECT recorded fewer major heart and blood-vessel events with branded semaglutide. Here is what the 20% headline means, who was studied, and where the evidence stops.
-
Semaglutide and Antidepressants: Can They Mix?
An antidepressant alone does not rule out semaglutide. The useful questions are how tablets are absorbed, how mood is doing, and what each medicine means for weight.
-
Should I Take Semaglutide? How a Provider Decides
A BMI of 32 can open the conversation. Medical history, current medicines and a workable follow-up plan determine where it goes.
-
When Was Rybelsus Approved? September 20, 2019
Rybelsus was approved on September 20, 2019. The FDA letter marked the moment a GLP-1 medicine moved from injection-only treatment into a daily tablet.
-
Does Semaglutide Cause Cancer? What Studies Show
Human studies have not established that semaglutide causes cancer. The thyroid warning remains, and lower cancer rates in some studies are not proof of prevention.
-
STEP 1 Trial Results: What the 14.9% Average Means
The 68-week semaglutide study found 14.9% average weight loss versus 2.4% with placebo. The details show who was studied, who stopped treatment and what happened later.
-
Tirzepatide and Kidney Disease: Risks and Evidence
Kidney disease does not automatically rule out tirzepatide. The key questions are dehydration risk, recent kidney tests and what the newer studies actually measured.
-
TrumpRx GLP-1 Prices: Beyond the Starting Price
Wegovy pills start at $149 and some pen offers at $199. Later fills, strength and eligibility determine the bill that follows.
-
503B Outsourcing Facility: What the Term Means
A 503B facility can prepare compounded medicines for clinic stock under federal manufacturing rules. Its registration describes the facility, not a review of each medicine.
-
15 Percent Weight Loss: What the Numbers Show
At 220 pounds, 15 percent is 33 pounds. Trials also measured waist, blood pressure, blood sugar, sleep, pain and physical function—but those group averages are not a personal forecast.
-
Who Discovered GLP-1? The Team Behind the Medicine
No single scientist discovered GLP-1. The answer is a chain of teams that found the gene, identified the working hormone, tested what it did, and designed medicines that lasted long enough to use.
-
FDA Tentative Approval: What It Means
FDA tentative approval means an application has cleared the scientific review needed for approval, but a legal barrier still prevents U.S. marketing. It is a real milestone, not permission to sell the drug.
-
Does Medicare Cover GLP-1 for Weight Loss? It Can
Some Medicare patients now qualify for a $50 monthly GLP-1 prescription. The Bridge has specific product and health requirements, and compounded prescriptions are outside it.
-
Semaglutide Meal Plan: A Simple Day Structure
A useful plan is flexible: smaller meals, protein early, fiber at a tolerable pace, and fluids across the day. This sample day uses portion ranges rather than a calorie rule.
-
Compounded Semaglutide Side Effects: What Changes?
Most compounded semaglutide side effects come from semaglutide itself. Compounding can add separate risks involving concentration, added ingredients, ingredient form, sterility, and labeling.
Page 1 of 5 · 96 articles